126 related articles for article (PubMed ID: 33531993)
1. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance.
Qu S; Zhang X; Wu Y; Li H; Zhai J; Wu D
J Cancer; 2021; 12(5):1483-1492. PubMed ID: 33531993
[TBL] [Abstract][Full Text] [Related]
2. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance.
Huang Y; Zhang J; Li H; Peng H; Gu M; Wang H
J Cancer; 2020; 11(22):6545-6555. PubMed ID: 33046975
[TBL] [Abstract][Full Text] [Related]
3. miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Han T; Zhang Y; Yang X; Han L; Li H; Chen T; Zheng Z
Mol Ther Nucleic Acids; 2020 Mar; 19():1073-1085. PubMed ID: 32044726
[TBL] [Abstract][Full Text] [Related]
4. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway.
Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z
Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112
[TBL] [Abstract][Full Text] [Related]
5. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
Lei Z; Tang X; Si A; Yang P; Wang L; Luo T; Guo G; Zhang Q; Cheng Z
Exp Cell Res; 2020 May; 390(1):111955. PubMed ID: 32165166
[TBL] [Abstract][Full Text] [Related]
6. miR-186 Inhibits Liver Cancer Stem Cells Expansion
Yao H; Yang Z; Lou Y; Huang J; Yang P; Jiang W; Chen S
Front Oncol; 2021; 11():632976. PubMed ID: 33816273
[TBL] [Abstract][Full Text] [Related]
7. miR-4461 Inhibits Liver Cancer Stem Cells Expansion and Chemoresistance via Regulating SIRT1.
Yang D; Zhang P; Yang Z; Hou G; Yang Z
Carcinogenesis; 2022 Nov; ():. PubMed ID: 36437743
[TBL] [Abstract][Full Text] [Related]
8. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.
Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J
Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356
[TBL] [Abstract][Full Text] [Related]
9. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance.
Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y
Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195
[TBL] [Abstract][Full Text] [Related]
10. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
Guo XL; Wang HB; Yong JK; Zhong J; Li QH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
[TBL] [Abstract][Full Text] [Related]
11. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
[TBL] [Abstract][Full Text] [Related]
12. miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.
Chen X; Tan W; Li W; Li W; Zhu S; Zhong J; Shang C; Chen Y
J Cancer; 2019; 10(12):2745-2753. PubMed ID: 31258782
[No Abstract] [Full Text] [Related]
13. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
Li L; Tang J; Zhang B; Yang W; LiuGao M; Wang R; Tan Y; Fan J; Chang Y; Fu J; Jiang F; Chen C; Yang Y; Gu J; Wu D; Guo L; Cao D; Li H; Cao G; Wu M; Zhang MQ; Chen L; Wang H
Gut; 2015 Jan; 64(1):156-67. PubMed ID: 24572141
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation.
Ma MKF; Lau EYT; Leung DHW; Lo J; Ho NPY; Cheng LKW; Ma S; Lin CH; Copland JA; Ding J; Lo RCL; Ng IOL; Lee TKW
J Hepatol; 2017 Nov; 67(5):979-990. PubMed ID: 28647567
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
17. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
18. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
19. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
20. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
